Found 6 matching trials
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy PHASE2 The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Show More Location
L-MARC Research Center
Learn More & Join Trial
Exploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCB NA Autologous arteriovenous fistula (AVF) is the preferred vascular pathway ty...
Show More Learn More & Join Trial
Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study PHASE4 This pilot study aims to evaluate whether a single dose of PCSK9 inhibitor ...
Show More Location
Multiple Locations
Learn More & Join Trial
In-hospital Initiation of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction N/A Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been ...
Show More Location
Multiple Locations
Learn More & Join Trial
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS) NA In this prospective, multicenter, open-label trial, 212 ACS patients will b...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients PHASE4 The goal of this clinical trial is to learn if drug tafolecimab works to tr...
Show More Location
Taihe County People's Hospital
Learn More & Join Trial